Please login to the form below

Not currently logged in
Email:
Password:

McKinsey

This page shows the latest McKinsey news and features for those working in and with pharma, biotech and healthcare.

Keeping it in the family pays dividends

Keeping it in the family pays dividends

It is clear the benefits leach into culture as a McKinsey survey of businesses owned by families and founders showed that 90% of board members said that family values were present

Latest news

  • I, Robot: How AI is redefining the use of data in healthcare I, Robot: How AI is redefining the use of data in healthcare

    McKinsey's analysis of this space has recently suggested that the use of data handling strategies for pharmaceutical research could create up to $100bn in cost savings per year, and that

  • A new era of collaboration A new era of collaboration

    A study by McKinsey found that if spending on health increases at the current rate, it will reach 50% of the GDP in most Organisation for Economic Cooperation and Development (OECD)

  • The Digital Patient The Digital Patient

    A 2014 survey from McKinsey &Co showed that three quarters of consumers in the UK, Germany and Singapore would like to make use of digital healthcare services – contrary to the perceived ... The McKinsey survey also exploded the myth that only younger

  • Novo Nordisk will work with IBM on diabetes care Novo Nordisk will work with IBM on diabetes care

    hold the key to revolutionising R&D and accelerating productivity - as laid out in a McKinsey &Co report published in 2013.

  • Teva takes controlling stake in genomics specialist Teva takes controlling stake in genomics specialist

    A 2013 report on personalised medicine by McKinsey &Co acknowledged the "tremendous potential" for this type of approach in CNS diseases whilst noting it is still in its infancy.

More from news
Approximately 0 fully matching, plus 27 partially matching documents found.

Latest Intelligence

  • Launch engagement Launch engagement

    Tailoring each launch. Launching a new product is never easy – 40% of worldwide drug launches between 2009 and 2017 failed to meet their two-year sales forecast, according to a McKinsey

  • Avoiding A Series of Unfortunate Events: launch lessons from lockdown Avoiding A Series of Unfortunate Events: launch lessons from lockdown

    The numbers tell a consistent story. In 2013, McKinsey/Evaluate estimated that around two-thirds of drug launches don’t meet sales expectations in the crucial first year on the market – ... Despite this, launch models have barely shifted. McKinsey

  • Rare genetic diseases – what’s in store for 2021? Rare genetic diseases – what’s in store for 2021?

    According to a report by McKinsey, Europe has a bright future in this sector with its world- class research institutions, medical centres and hospitals.

  • Is creativity in quarantine? Is creativity in quarantine?

    According to McKinsey – that, in 2017, developed an index to benchmark creativity based on awarded work at the Cannes Lions Festival – creative leaders outperform their peers on three key financial measures:

  • Shaping the organisation to enable intelligent, precision engagement Shaping the organisation to enable intelligent, precision engagement

    McKinsey’s October 2020 Update on EU physician experiences, expectations and perspectives on pharma engagement also highlights the rise in in-patient consultations and the changing shape of the omni-channel

More from intelligence
Approximately 0 fully matching, plus 29 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 12 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....